Nuclear Medicine & Radiopharmaceuticals Market - Global Outlook and Forecast 2021-2027
This report contains market size and forecasts of Nuclear Medicine & Radiopharmaceuticals in global, including the following market information:
Global Nuclear Medicine & Radiopharmaceuticals Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Nuclear Medicine & Radiopharmaceuticals Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Nuclear Medicine & Radiopharmaceuticals companies in 2020 (%)
The global Nuclear Medicine & Radiopharmaceuticals market was valued at 5593 million in 2020 and is projected to reach US$ 7558.2 million by 2027, at a CAGR of 7.8% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nuclear Medicine & Radiopharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nuclear Medicine & Radiopharmaceuticals Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Nuclear Medicine & Radiopharmaceuticals Market Segment Percentages, By Type, 2020 (%)
Global Nuclear Medicine & Radiopharmaceuticals Market Segment Percentages, By Application, 2020 (%)
Global Nuclear Medicine & Radiopharmaceuticals Market Segment Percentages, By Region and Country, 2020 (%)
The report also provides analysis of leading market participants including:
Key companies Nuclear Medicine & Radiopharmaceuticals revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Nuclear Medicine & Radiopharmaceuticals revenues share in global market, 2020 (%)
Key companies Nuclear Medicine & Radiopharmaceuticals sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Nuclear Medicine & Radiopharmaceuticals sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Nuclear Medicine & Radiopharmaceuticals Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Nuclear Medicine & Radiopharmaceuticals Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Nuclear Medicine & Radiopharmaceuticals companies in 2020 (%)
The global Nuclear Medicine & Radiopharmaceuticals market was valued at 5593 million in 2020 and is projected to reach US$ 7558.2 million by 2027, at a CAGR of 7.8% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nuclear Medicine & Radiopharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nuclear Medicine & Radiopharmaceuticals Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Nuclear Medicine & Radiopharmaceuticals Market Segment Percentages, By Type, 2020 (%)
- Diagnostic
- Therapeutic
Global Nuclear Medicine & Radiopharmaceuticals Market Segment Percentages, By Application, 2020 (%)
- Oncology
- Thyroid
- Cardiology
Global Nuclear Medicine & Radiopharmaceuticals Market Segment Percentages, By Region and Country, 2020 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Nuclear Medicine & Radiopharmaceuticals revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Nuclear Medicine & Radiopharmaceuticals revenues share in global market, 2020 (%)
Key companies Nuclear Medicine & Radiopharmaceuticals sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Nuclear Medicine & Radiopharmaceuticals sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
- China Isotope & Radiation
- Dongcheng
- Jaco
- Ciaeriar
- Advanced Molecular-imaging Solution
- Shanghai Atom Kexing
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Nuclear Medicine & Radiopharmaceuticals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nuclear Medicine & Radiopharmaceuticals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS OVERALL MARKET SIZE
2.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size: 2021 VS 2027
2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Nuclear Medicine & Radiopharmaceuticals Sales (Consumption): 2016-2027
3 COMPANY LANDSCAPE
3.1 Top Nuclear Medicine & Radiopharmaceuticals Players in Global Market
3.2 Top Global Nuclear Medicine & Radiopharmaceuticals Companies Ranked by Revenue
3.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Companies
3.4 Global Nuclear Medicine & Radiopharmaceuticals Sales by Companies
3.5 Global Nuclear Medicine & Radiopharmaceuticals Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Nuclear Medicine & Radiopharmaceuticals Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nuclear Medicine & Radiopharmaceuticals Players in Global Market
3.8.1 List of Global Tier 1 Nuclear Medicine & Radiopharmaceuticals Companies
3.8.2 List of Global Tier 2 and Tier 3 Nuclear Medicine & Radiopharmaceuticals Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Nuclear Medicine & Radiopharmaceuticals Market Size Markets, 2021 & 2027
4.1.2 Diagnostic
4.1.3 Therapeutic
4.2 By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue & Forecasts
4.2.1 By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2016-2021
4.2.2 By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2022-2027
4.2.3 By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2016-2027
4.3 By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales & Forecasts
4.3.1 By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales, 2016-2021
4.3.2 By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales, 2022-2027
4.3.3 By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2016-2027
4.4 By Type - Global Nuclear Medicine & Radiopharmaceuticals Price (Manufacturers Selling Prices), 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Nuclear Medicine & Radiopharmaceuticals Market Size, 2021 & 2027
5.1.2 Oncology
5.1.3 Thyroid
5.1.4 Cardiology
5.2 By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue & Forecasts
5.2.1 By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2016-2021
5.2.2 By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2022-2027
5.2.3 By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2016-2027
5.3 By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales & Forecasts
5.3.1 By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales, 2016-2021
5.3.2 By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales, 2022-2027
5.3.3 By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2016-2027
5.4 By Application - Global Nuclear Medicine & Radiopharmaceuticals Price (Manufacturers Selling Prices), 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global Nuclear Medicine & Radiopharmaceuticals Market Size, 2021 & 2027
6.2 By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue & Forecasts
6.2.1 By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2016-2021
6.2.2 By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2022-2027
6.2.3 By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2016-2027
6.3 By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales & Forecasts
6.3.1 By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales, 2016-2021
6.3.2 By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales, 2022-2027
6.3.3 By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Nuclear Medicine & Radiopharmaceuticals Revenue, 2016-2027
6.4.2 By Country - North America Nuclear Medicine & Radiopharmaceuticals Sales, 2016-2027
6.4.3 US Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.4.4 Canada Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.4.5 Mexico Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Nuclear Medicine & Radiopharmaceuticals Revenue, 2016-2027
6.5.2 By Country - Europe Nuclear Medicine & Radiopharmaceuticals Sales, 2016-2027
6.5.3 Germany Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.5.4 France Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.5.5 U.K. Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.5.6 Italy Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.5.7 Russia Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.5.8 Nordic Countries Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.5.9 Benelux Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Nuclear Medicine & Radiopharmaceuticals Revenue, 2016-2027
6.6.2 By Region - Asia Nuclear Medicine & Radiopharmaceuticals Sales, 2016-2027
6.6.3 China Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.6.4 Japan Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.6.5 South Korea Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.6.6 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.6.7 India Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Nuclear Medicine & Radiopharmaceuticals Revenue, 2016-2027
6.7.2 By Country - South America Nuclear Medicine & Radiopharmaceuticals Sales, 2016-2027
6.7.3 Brazil Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.7.4 Argentina Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales, 2016-2027
6.8.3 Turkey Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.8.4 Israel Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.8.5 Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.8.6 UAE Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
7 MANUFACTURERS & BRANDS PROFILES
7.1 China Isotope & Radiation
7.1.1 China Isotope & Radiation Corporate Summary
7.1.2 China Isotope & Radiation Business Overview
7.1.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Major Product Offerings
7.1.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales and Revenue in Global (2016-2021)
7.1.5 China Isotope & Radiation Key News
7.2 Dongcheng
7.2.1 Dongcheng Corporate Summary
7.2.2 Dongcheng Business Overview
7.2.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Major Product Offerings
7.2.4 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales and Revenue in Global (2016-2021)
7.2.5 Dongcheng Key News
7.3 Jaco
7.3.1 Jaco Corporate Summary
7.3.2 Jaco Business Overview
7.3.3 Jaco Nuclear Medicine & Radiopharmaceuticals Major Product Offerings
7.3.4 Jaco Nuclear Medicine & Radiopharmaceuticals Sales and Revenue in Global (2016-2021)
7.3.5 Jaco Key News
7.4 Ciaeriar
7.4.1 Ciaeriar Corporate Summary
7.4.2 Ciaeriar Business Overview
7.4.3 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Major Product Offerings
7.4.4 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales and Revenue in Global (2016-2021)
7.4.5 Ciaeriar Key News
7.5 Advanced Molecular-imaging Solution
7.5.1 Advanced Molecular-imaging Solution Corporate Summary
7.5.2 Advanced Molecular-imaging Solution Business Overview
7.5.3 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Major Product Offerings
7.5.4 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales and Revenue in Global (2016-2021)
7.5.5 Advanced Molecular-imaging Solution Key News
7.6 Shanghai Atom Kexing
7.6.1 Shanghai Atom Kexing Corporate Summary
7.6.2 Shanghai Atom Kexing Business Overview
7.6.3 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Major Product Offerings
7.6.4 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales and Revenue in Global (2016-2021)
7.6.5 Shanghai Atom Kexing Key News
8 GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Nuclear Medicine & Radiopharmaceuticals Production Capacity, 2016-2027
8.2 Nuclear Medicine & Radiopharmaceuticals Production Capacity of Key Manufacturers in Global Market
8.3 Global Nuclear Medicine & Radiopharmaceuticals Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 NUCLEAR MEDICINE & RADIOPHARMACEUTICALS SUPPLY CHAIN ANALYSIS
10.1 Nuclear Medicine & Radiopharmaceuticals Industry Value Chain
10.2 Nuclear Medicine & Radiopharmaceuticals Upstream Market
10.3 Nuclear Medicine & Radiopharmaceuticals Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Nuclear Medicine & Radiopharmaceuticals Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Nuclear Medicine & Radiopharmaceuticals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nuclear Medicine & Radiopharmaceuticals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS OVERALL MARKET SIZE
2.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size: 2021 VS 2027
2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Nuclear Medicine & Radiopharmaceuticals Sales (Consumption): 2016-2027
3 COMPANY LANDSCAPE
3.1 Top Nuclear Medicine & Radiopharmaceuticals Players in Global Market
3.2 Top Global Nuclear Medicine & Radiopharmaceuticals Companies Ranked by Revenue
3.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Companies
3.4 Global Nuclear Medicine & Radiopharmaceuticals Sales by Companies
3.5 Global Nuclear Medicine & Radiopharmaceuticals Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Nuclear Medicine & Radiopharmaceuticals Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nuclear Medicine & Radiopharmaceuticals Players in Global Market
3.8.1 List of Global Tier 1 Nuclear Medicine & Radiopharmaceuticals Companies
3.8.2 List of Global Tier 2 and Tier 3 Nuclear Medicine & Radiopharmaceuticals Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Nuclear Medicine & Radiopharmaceuticals Market Size Markets, 2021 & 2027
4.1.2 Diagnostic
4.1.3 Therapeutic
4.2 By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue & Forecasts
4.2.1 By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2016-2021
4.2.2 By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2022-2027
4.2.3 By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2016-2027
4.3 By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales & Forecasts
4.3.1 By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales, 2016-2021
4.3.2 By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales, 2022-2027
4.3.3 By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2016-2027
4.4 By Type - Global Nuclear Medicine & Radiopharmaceuticals Price (Manufacturers Selling Prices), 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Nuclear Medicine & Radiopharmaceuticals Market Size, 2021 & 2027
5.1.2 Oncology
5.1.3 Thyroid
5.1.4 Cardiology
5.2 By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue & Forecasts
5.2.1 By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2016-2021
5.2.2 By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2022-2027
5.2.3 By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2016-2027
5.3 By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales & Forecasts
5.3.1 By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales, 2016-2021
5.3.2 By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales, 2022-2027
5.3.3 By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2016-2027
5.4 By Application - Global Nuclear Medicine & Radiopharmaceuticals Price (Manufacturers Selling Prices), 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global Nuclear Medicine & Radiopharmaceuticals Market Size, 2021 & 2027
6.2 By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue & Forecasts
6.2.1 By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2016-2021
6.2.2 By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2022-2027
6.2.3 By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2016-2027
6.3 By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales & Forecasts
6.3.1 By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales, 2016-2021
6.3.2 By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales, 2022-2027
6.3.3 By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Nuclear Medicine & Radiopharmaceuticals Revenue, 2016-2027
6.4.2 By Country - North America Nuclear Medicine & Radiopharmaceuticals Sales, 2016-2027
6.4.3 US Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.4.4 Canada Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.4.5 Mexico Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Nuclear Medicine & Radiopharmaceuticals Revenue, 2016-2027
6.5.2 By Country - Europe Nuclear Medicine & Radiopharmaceuticals Sales, 2016-2027
6.5.3 Germany Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.5.4 France Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.5.5 U.K. Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.5.6 Italy Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.5.7 Russia Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.5.8 Nordic Countries Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.5.9 Benelux Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Nuclear Medicine & Radiopharmaceuticals Revenue, 2016-2027
6.6.2 By Region - Asia Nuclear Medicine & Radiopharmaceuticals Sales, 2016-2027
6.6.3 China Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.6.4 Japan Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.6.5 South Korea Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.6.6 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.6.7 India Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Nuclear Medicine & Radiopharmaceuticals Revenue, 2016-2027
6.7.2 By Country - South America Nuclear Medicine & Radiopharmaceuticals Sales, 2016-2027
6.7.3 Brazil Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.7.4 Argentina Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales, 2016-2027
6.8.3 Turkey Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.8.4 Israel Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.8.5 Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
6.8.6 UAE Nuclear Medicine & Radiopharmaceuticals Market Size, 2016-2027
7 MANUFACTURERS & BRANDS PROFILES
7.1 China Isotope & Radiation
7.1.1 China Isotope & Radiation Corporate Summary
7.1.2 China Isotope & Radiation Business Overview
7.1.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Major Product Offerings
7.1.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales and Revenue in Global (2016-2021)
7.1.5 China Isotope & Radiation Key News
7.2 Dongcheng
7.2.1 Dongcheng Corporate Summary
7.2.2 Dongcheng Business Overview
7.2.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Major Product Offerings
7.2.4 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales and Revenue in Global (2016-2021)
7.2.5 Dongcheng Key News
7.3 Jaco
7.3.1 Jaco Corporate Summary
7.3.2 Jaco Business Overview
7.3.3 Jaco Nuclear Medicine & Radiopharmaceuticals Major Product Offerings
7.3.4 Jaco Nuclear Medicine & Radiopharmaceuticals Sales and Revenue in Global (2016-2021)
7.3.5 Jaco Key News
7.4 Ciaeriar
7.4.1 Ciaeriar Corporate Summary
7.4.2 Ciaeriar Business Overview
7.4.3 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Major Product Offerings
7.4.4 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales and Revenue in Global (2016-2021)
7.4.5 Ciaeriar Key News
7.5 Advanced Molecular-imaging Solution
7.5.1 Advanced Molecular-imaging Solution Corporate Summary
7.5.2 Advanced Molecular-imaging Solution Business Overview
7.5.3 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Major Product Offerings
7.5.4 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales and Revenue in Global (2016-2021)
7.5.5 Advanced Molecular-imaging Solution Key News
7.6 Shanghai Atom Kexing
7.6.1 Shanghai Atom Kexing Corporate Summary
7.6.2 Shanghai Atom Kexing Business Overview
7.6.3 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Major Product Offerings
7.6.4 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales and Revenue in Global (2016-2021)
7.6.5 Shanghai Atom Kexing Key News
8 GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Nuclear Medicine & Radiopharmaceuticals Production Capacity, 2016-2027
8.2 Nuclear Medicine & Radiopharmaceuticals Production Capacity of Key Manufacturers in Global Market
8.3 Global Nuclear Medicine & Radiopharmaceuticals Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 NUCLEAR MEDICINE & RADIOPHARMACEUTICALS SUPPLY CHAIN ANALYSIS
10.1 Nuclear Medicine & Radiopharmaceuticals Industry Value Chain
10.2 Nuclear Medicine & Radiopharmaceuticals Upstream Market
10.3 Nuclear Medicine & Radiopharmaceuticals Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Nuclear Medicine & Radiopharmaceuticals Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Nuclear Medicine & Radiopharmaceuticals in Global Market
Table 2. Top Nuclear Medicine & Radiopharmaceuticals Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Companies, 2016-2021
Table 5. Global Nuclear Medicine & Radiopharmaceuticals Sales by Companies, (K Units), 2016-2021
Table 6. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Nuclear Medicine & Radiopharmaceuticals Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Type
Table 9. List of Global Tier 1 Nuclear Medicine & Radiopharmaceuticals Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nuclear Medicine & Radiopharmaceuticals Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units), 2016-2021
Table 15. By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units), 2022-2027
Table 16. By Application – Global Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units), 2016-2021
Table 20. By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units), 2022-2027
Table 21. By Region – Global Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units), 2016-2021
Table 25. By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units), 2022-2027
Table 26. By Country - North America Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2016-2021
Table 29. By Country - North America Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2022-2027
Table 30. By Country - Europe Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2016-2021
Table 33. By Country - Europe Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2022-2027
Table 34. By Region - Asia Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2016-2021
Table 37. By Region - Asia Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2022-2027
Table 38. By Country - South America Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2016-2021
Table 41. By Country - South America Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2022-2027
Table 46. China Isotope & Radiation Corporate Summary
Table 47. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Offerings
Table 48. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 49. Dongcheng Corporate Summary
Table 50. Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Offerings
Table 51. Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 52. Jaco Corporate Summary
Table 53. Jaco Nuclear Medicine & Radiopharmaceuticals Product Offerings
Table 54. Jaco Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 55. Ciaeriar Corporate Summary
Table 56. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product Offerings
Table 57. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 58. Advanced Molecular-imaging Solution Corporate Summary
Table 59. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product Offerings
Table 60. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 61. Shanghai Atom Kexing Corporate Summary
Table 62. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product Offerings
Table 63. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 64. Nuclear Medicine & Radiopharmaceuticals Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 65. Global Nuclear Medicine & Radiopharmaceuticals Capacity Market Share of Key Manufacturers, 2019-2021
Table 66. Global Nuclear Medicine & Radiopharmaceuticals Production by Region, 2016-2021 (K Units)
Table 67. Global Nuclear Medicine & Radiopharmaceuticals Production by Region, 2022-2027 (K Units)
Table 68. Nuclear Medicine & Radiopharmaceuticals Market Opportunities & Trends in Global Market
Table 69. Nuclear Medicine & Radiopharmaceuticals Market Drivers in Global Market
Table 70. Nuclear Medicine & Radiopharmaceuticals Market Restraints in Global Market
Table 71. Nuclear Medicine & Radiopharmaceuticals Raw Materials
Table 72. Nuclear Medicine & Radiopharmaceuticals Raw Materials Suppliers in Global Market
Table 73. Typical Nuclear Medicine & Radiopharmaceuticals Downstream
Table 74. Nuclear Medicine & Radiopharmaceuticals Downstream Clients in Global Market
Table 75. Nuclear Medicine & Radiopharmaceuticals Distributors and Sales Agents in Global Market
Table 1. Key Players of Nuclear Medicine & Radiopharmaceuticals in Global Market
Table 2. Top Nuclear Medicine & Radiopharmaceuticals Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Companies, 2016-2021
Table 5. Global Nuclear Medicine & Radiopharmaceuticals Sales by Companies, (K Units), 2016-2021
Table 6. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Nuclear Medicine & Radiopharmaceuticals Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Type
Table 9. List of Global Tier 1 Nuclear Medicine & Radiopharmaceuticals Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nuclear Medicine & Radiopharmaceuticals Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units), 2016-2021
Table 15. By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units), 2022-2027
Table 16. By Application – Global Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units), 2016-2021
Table 20. By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units), 2022-2027
Table 21. By Region – Global Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units), 2016-2021
Table 25. By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units), 2022-2027
Table 26. By Country - North America Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2016-2021
Table 29. By Country - North America Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2022-2027
Table 30. By Country - Europe Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2016-2021
Table 33. By Country - Europe Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2022-2027
Table 34. By Region - Asia Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2016-2021
Table 37. By Region - Asia Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2022-2027
Table 38. By Country - South America Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2016-2021
Table 41. By Country - South America Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2022-2027
Table 46. China Isotope & Radiation Corporate Summary
Table 47. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Offerings
Table 48. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 49. Dongcheng Corporate Summary
Table 50. Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Offerings
Table 51. Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 52. Jaco Corporate Summary
Table 53. Jaco Nuclear Medicine & Radiopharmaceuticals Product Offerings
Table 54. Jaco Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 55. Ciaeriar Corporate Summary
Table 56. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product Offerings
Table 57. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 58. Advanced Molecular-imaging Solution Corporate Summary
Table 59. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product Offerings
Table 60. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 61. Shanghai Atom Kexing Corporate Summary
Table 62. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product Offerings
Table 63. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 64. Nuclear Medicine & Radiopharmaceuticals Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 65. Global Nuclear Medicine & Radiopharmaceuticals Capacity Market Share of Key Manufacturers, 2019-2021
Table 66. Global Nuclear Medicine & Radiopharmaceuticals Production by Region, 2016-2021 (K Units)
Table 67. Global Nuclear Medicine & Radiopharmaceuticals Production by Region, 2022-2027 (K Units)
Table 68. Nuclear Medicine & Radiopharmaceuticals Market Opportunities & Trends in Global Market
Table 69. Nuclear Medicine & Radiopharmaceuticals Market Drivers in Global Market
Table 70. Nuclear Medicine & Radiopharmaceuticals Market Restraints in Global Market
Table 71. Nuclear Medicine & Radiopharmaceuticals Raw Materials
Table 72. Nuclear Medicine & Radiopharmaceuticals Raw Materials Suppliers in Global Market
Table 73. Typical Nuclear Medicine & Radiopharmaceuticals Downstream
Table 74. Nuclear Medicine & Radiopharmaceuticals Downstream Clients in Global Market
Table 75. Nuclear Medicine & Radiopharmaceuticals Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Nuclear Medicine & Radiopharmaceuticals Segment by Type
Figure 2. Nuclear Medicine & Radiopharmaceuticals Segment by Application
Figure 3. Global Nuclear Medicine & Radiopharmaceuticals Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Nuclear Medicine & Radiopharmaceuticals Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2016-2027 (US$, Mn)
Figure 7. Nuclear Medicine & Radiopharmaceuticals Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Nuclear Medicine & Radiopharmaceuticals Revenue in 2020
Figure 9. By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2016-2027
Figure 10. By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2016-2027
Figure 11. By Type - Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit), 2016-2027
Figure 12. By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2016-2027
Figure 13. By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2016-2027
Figure 14. By Application - Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit), 2016-2027
Figure 15. By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2016-2027
Figure 16. By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2016-2027
Figure 17. By Country - North America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2016-2027
Figure 18. By Country - North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2016-2027
Figure 19. US Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2016-2027
Figure 24. Germany Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 25. France Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2016-2027
Figure 33. China Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 37. India Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2016-2027
Figure 39. By Country - South America Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2016-2027
Figure 40. Brazil Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2016-2027
Figure 44. Turkey Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 48. Global Nuclear Medicine & Radiopharmaceuticals Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Nuclear Medicine & Radiopharmaceuticals by Region, 2020 VS 2027
Figure 50. Nuclear Medicine & Radiopharmaceuticals Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Nuclear Medicine & Radiopharmaceuticals Segment by Type
Figure 2. Nuclear Medicine & Radiopharmaceuticals Segment by Application
Figure 3. Global Nuclear Medicine & Radiopharmaceuticals Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Nuclear Medicine & Radiopharmaceuticals Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2016-2027 (US$, Mn)
Figure 7. Nuclear Medicine & Radiopharmaceuticals Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Nuclear Medicine & Radiopharmaceuticals Revenue in 2020
Figure 9. By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2016-2027
Figure 10. By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2016-2027
Figure 11. By Type - Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit), 2016-2027
Figure 12. By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2016-2027
Figure 13. By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2016-2027
Figure 14. By Application - Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit), 2016-2027
Figure 15. By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2016-2027
Figure 16. By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2016-2027
Figure 17. By Country - North America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2016-2027
Figure 18. By Country - North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2016-2027
Figure 19. US Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2016-2027
Figure 24. Germany Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 25. France Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2016-2027
Figure 33. China Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 37. India Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2016-2027
Figure 39. By Country - South America Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2016-2027
Figure 40. Brazil Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2016-2027
Figure 44. Turkey Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2016-2027
Figure 48. Global Nuclear Medicine & Radiopharmaceuticals Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Nuclear Medicine & Radiopharmaceuticals by Region, 2020 VS 2027
Figure 50. Nuclear Medicine & Radiopharmaceuticals Industry Value Chain
Figure 51. Marketing Channels
